Prof. Cem Aygün is a hepatology and gastroenterology specialist with extensive clinical and academic experience. He earned an associate professorship from Fırat University Faculty of Medicine in 2011–2012 and has been affiliated with Acıbadem Health Group since 2020. His professional focus includes liver disease diagnosis and management, gastrointestinal endoscopy, and research in hepatology. He is an active member of several national and international societies, including the Turkish Gastroenterology Association, Liver Research Society of Turkey, Turkish Association for Liver Research, European Association for the Study of the Liver (EASL), and the European Society of Gastrointestinal Endoscopy (ESGE).
Education
- 2011 – 2012 Firat University Faculty of Medicine / Associate Professor
- 2009 – 2011 Firat University Faculty of Medicine / Assistant Professor
- 2007 Kocaeli University Faculty of Medicine Gastroenterology
- 2001 Istanbul University Cerrahpaşa Faculty of Medicine Internal Medicine
- 1996 Hacettepe University Faculty of Medicine
Experience
- 2020 Acibadem Health Group
- 2012 – 2015 Istanbul Medipol University Faculty of Medicine / Gastroenterology (EUS, ERCP, motility) Unit Founder and Responsible
- 2012 University College of London, Endoscopic Ultrasound / Clinical Observer
- 2009 – 2012 Firat University Faculty of Medicine / ECTS and ERASMUS Exchange Program Faculty Representative
- 2009 – 2012 Firat University Faculty of Medicine / Faculty Member
- 2008 – 2009 Adıyaman State Hospital / Compulsory Service
Memberships
- Turkish Gastroenterology Association
- Liver Research Society of Turkey
- European Association for The Study of The Liver
- Turkish Association for Liver Research
- European Society of Gastrointestinal Endoscopy
- Turkish Gastroenterology Association
Publications
- Methylenetetrahydrofolate reductase gene polymorphisms in patients with nonalcoholic steatohepatitis (NASH).
Cell Biochem Funct. 2008 Apr;26(3):291-6. A.Sazci, E.Ergul, C.Aygun, G.Akpinar, O.Senturk, S.Hulagu. - Endothelial dysfunction in Turkish patients with non-alcoholic fatty liver disease.
Intern Med J. 2008 Mar;38(3):183-9. O.Senturk, O.Kocaman, S.Hulagu, T.Sahin, C.Aygun, T.Konduk, A.Celebi. - Adiponectin: is it a novel treatment modality to alleviate liver injury in non-alcoholic fatty liver disease (NAFLD)?
Med Hypotheses. 2008;70(2):457-8. C.Aygun, O.Kocaman, O.Senturk. - A rare gastric outlet anomaly: pyloric ostium on incissura angularis.
Dig Dis Sci. 2007 Apr;52(4):1001-3. S.Uraz, C.Aygun, T.Konduk, A.Celebi, O.Senturk, S.Hulagu. - Clindamycin-induced acute cholestatic hepatitis.
World J Gastroenterol. 2007 Oct 28;13(40):5408-10. C.Aygun, O.Kocaman, Y.Gurbuz, O.Senturk, S.Hulagu. - Granular cell tumor of esophagus removed with endoscopic submucosal dissection.
Turk J Gastroenterol. 2007 Sep;18(3):188-91. S.Hulagu, O.Senturk, C.Aygun, Y.Gurbuz, O.Kocaman, A.Celebi, T.Konduk. - Pieces of trash bag in the stomach.
Turk J Gastroenterol. 2007 Sep;18(3):210-1. O.Kocaman, C.Aygun, T.Konduk, A.Celebi, O.Senturk, S.Hulagu. - Burst of autoimmunity with the emergence of primary Sjogren’s syndrome, cholestatic autoimmune hepatitis and latent, autoimmune diabetes of adults (LADA).
South Med J. 2006 Sep;99(9):1014-5. O.Kocaman, C.Aygun, Y.Gurbuz, A.Cefle, T.Konduk, O.Senturk, A.Celebi, S.Hulagu. - Endothelial dysfunction in patients with ulcerative colitis.
Inflamm Bowel Dis. 2006 Mar;12(3): 166-71. O.Kocaman, T.Sahin, C.Aygun, O.Senturk, S.Hulagu. - Serum levels of hepatoprotective peptide adiponectin in non¬alcoholic fatty liver disease.
Eur J Gastroenterol Hepatol. 2006 Feb;18(2):175-80. C.Aygun, O.Senturk, S.Hulagu, S.Uraz , A.Celebi, T.Konduk, B.Mutlu, Z.Canturk.
